Bayer completes sale of its Environmental Science Professional business to Cinven

Leverkusen, October 5, 2022 – Bayer has completed the sale of its Environmental Science Professional business to the international private equity firm Cinven, after the two companies had entered into a corresponding agreement in March. The conditions for closing the transaction – including the receipt of regulatory approval – have now been met. The purchase price for the business, which generated sales of approximately 600 million euros in 2021, amounts to 2.6 billion U.S. dollars (2.6 billion euros).

“We thank the employees of Environmental Science Professional for their many years of commitment and the associated success of Bayer. In Cinven, we have found a strong new owner with a firm commitment to the long-term growth potential of the business and to its people,” said Rodrigo Santos, member of the Board of Management of Bayer AG and head of the Crop Science Division. “At the same time, we can concentrate on our core agricultural business and the successful implementation of our growth strategy in the Crop Science Division.” Bayer will use the net proceeds from the transaction to reduce its net financial debt.

The divested business is set to operate as an independent company called Envu. The business is a global leader offering solutions to control pests, disease and weeds in non-agricultural areas such as vector control, professional pest management, vegetation management, forestry, and turf and ornamentals. It is headquartered in Cary, North Carolina, United States, and is active in over 100 countries. Nearly 900 employees in total will transfer from Bayer to Envu.

“Envu is a global leader in a highly attractive and critical industry. We thank Bayer for the trust they have placed in Cinven and plan to build on the strong foundations established by Bayer by significantly investing in it,” said Pontus Pettersson, Partner at Cinven. “Cinven is excited to build an independent, focused company and is well positioned to continue to drive innovation and accelerate growth, including the delivery of digital and data-enabled solutions, and to extend the product portfolio further by creating innovative and sustainable solutions for its customers.”

About Envu

Envu was founded in 2022, a new company built on years of Bayer experience, for the sole purpose of advancing healthy environments for everyone, everywhere. Envu offers dedicated services in: Professional Pest Management, Forestry, Ornamentals, Golf, Industrial Vegetation Management, Lawn & Landscape, Mosquito Management, and Range & Pasture. Across each of its lines of business, Envu focuses its work in chemistry and beyond, collaborating with customers to come up with innovative solutions that will work today and well into the future. Envu’s portfolio consists of over 180 trusted and well-known brands. The company employs nearly 900 people and operates in more than 100 countries with four global innovation hubs. For additional information, visit the Envu website.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.

About Cinven

Cinven is a leading international private equity firm focused on building world-class global companies. Its funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials and TMT (Technology, Media and Telecommunications). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid, Guernsey and Luxembourg. Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society. www.cinven.com

The Envu logo can be found here.

2022-0161.jpg

Find more information at www.bayer.com.

Follow us on Twitter https://twitter.com/bayer

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
An RSV Vaccine Was Approved for What Group? thumbnail

An RSV Vaccine Was Approved for What Group?

Quizzes > Weekly News Quiz — You passed medical training, now see if you can pass our weekly quiz by MedPage Today Staff May 6, 2023 The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up
Read More

A forma de administrar adenosina na taquicardia supraventricular faz diferença?

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed O Portal PEBMED é destinado para médicos e demais profissionais de saúde. Nossos conteúdos informam panoramas recentes da medicina. Caso tenha interesse em divulgar seu currículo na internet,…
Read More
Lee Nak-yeon “The budget for small business owners and the self-employed should be set at 40 trillion won” thumbnail

Lee Nak-yeon “The budget for small business owners and the self-employed should be set at 40 trillion won”

“보상 없는 희생, 약자에 대한 폭력… 공동체 붕괴 가속” 더불어민주당 이낙연 대선 경선 후보가 28일 국회 소통관에서 '위드코로나 소상공인 특별대책’ 발표 기자회견을 마친 뒤 취재진의 질문에 답하고 있다. 국회사진기자단 더불어민주당 이낙연 대선 경선 후보는 28일 소상공인과 자영업자를 위한 40조원 규모의 추가 재정 투입을 이번 정기국회 기간 동안 논의하자고 했다. 코로나19 장기화로 소상공인·자영업자 손실이 누적되는 가운데, 회복이 더디어질수록 더 큰…
Read More
Have IBD and Insomnia? You’re Not Alone thumbnail

Have IBD and Insomnia? You’re Not Alone

Please enable cookies. Error 1005 Ray ID: 7bb163efaf291bc6 • 2023-04-21 00:08:03 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 7bb163efaf291bc6 • Your IP: 89.117.245.16 •
Read More
Newly discovered DNA repair mechanisms point to potential therapy targets for cancer and neurodegenerative diseases thumbnail

Newly discovered DNA repair mechanisms point to potential therapy targets for cancer and neurodegenerative diseases

3D-model of DNA. Credit: Michael Ströck/Wikimedia/ GNU Free Documentation License The DNA that lies tightly coiled in nearly every human cell is subjected to thousands of insults and injuries from within and without daily, which is why the human body has evolved multiple highly effective mechanisms for repairing DNA damage. "We have in place exquisite…
Read More
Index Of News
Total
0
Share